UNSPSC 51201831: Lipegfilgrastim

Lipegfilgrastim is a medication used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adults. It is given by injection under the skin in the abdomen, upper arm or thigh.

UNSPSC 51201831 Lipegfilgrastim, a Commodity code, shows no relevant recent state and local procurement activity. The source contains no solicitations for this specific pharmaceutical product or any closely related biologic agents. The recent opportunities tagged to this code include unrelated notices: a county purchasing department relocation announcement, a reverse trade show networking event for Marion County, a vendor forum for Williamson County, and a county purchasing department survey—none of which involve procurement of lipegfilgrastim or similar hematopoietic agents. Two opportunities nominally tagged to the code—Seminole County's procurement of naloxone and drug deactivation systems, and the City of Tucson Fire Department's request for BLS/ALS pharmaceuticals and supplies—address emergency response drugs and medical supplies wholly outside the scope of this specialized oncology supportive-care therapeutic.

State and local governments do not appear to be buying lipegfilgrastim directly under this code at present. The code's nominal scope—a long-acting granulocyte colony-stimulating factor (G-CSF) used to reduce infection risk in chemotherapy patients—differs sharply from the pharmaceutical procurement being tagged to it in the available record. No issuing bodies, response dates, contract values, geographic spread, or representative recent opportunities support pursuit under this code. Watch for activity in state Medicaid procurement channels, cancer center supply contracts, or hospital system pharmacy RFPs, but the current dataset does not surface actionable market signals here.